Imbalance of Amniotic Fluid Activin-A and Follistatin in Intraamniotic Infection, Inflammation, and Preterm Birth

John T Hardy1, Irina A Buhimschi1, Megan E McCarthy1

  • 1Department of Obstetrics/Gynecology and Reproductive Sciences (J.T.H., M.E.M., C.A.L., L.L.S.), Yale University School of Medicine, New Haven, Connecticut 06520; Center for Perinatal Research (I.A.B., G.Z.), The Research Institute at Nationwide Children's Hospital, and Department of Pediatrics (I.A.B.), The Ohio State University College of Medicine, Columbus, Ohio 43215; and Department of Obstetrics/Gynecology (I.A.B., C.S.B.), The Ohio State University College of Medicine, Columbus, Ohio 43210.

Abstract

Insights

Activin-A and follistatin in amniotic fluid influence preterm birth (PTB) by modulating inflammatory pathways. An imbalanced activin-A to follistatin ratio, especially during infection, correlates with PTB and preterm premature rupture of membranes (PPROM).

Area of Science:

  • Reproductive biology
  • Maternal-fetal medicine
  • Inflammation research

Background:

  • Microbial invasion of amniotic fluid triggers inflammation involving activin-A.
  • Follistatin, an activin-A inhibitor, is present in amniotic fluid, but its role in inflammation-induced preterm birth (PTB) is unclear.

Purpose of the Study:

  • Investigate the relationship between activin-A and follistatin in amniotic fluid during normal and preterm labor.
  • Evaluate the role of the activin-A-follistatin balance in PTB and preterm premature rupture of membranes (PPROM).

Main Methods:

  • Immunoassay of amniotic fluid activin-A and follistatin in 168 women.
  • In vitro study using amniochorion explants challenged with lipopolysaccharide (LPS) to assess the impact of activin-A/follistatin imbalance on PTB pathways.

Main Results:

  • Amniotic fluid follistatin and the activin-A to follistatin ratio decrease with gestational age.
  • Infection elevates activin-A and the activin-A/follistatin ratio, correlating with inflammation severity.
  • Activin-A upregulates prostaglandins and matrix metalloproteinases (MMPs); follistatin partially counteracts these effects.

Conclusions:

  • Activin-A and follistatin are key components of the gestational sac's inflammatory response to infection.
  • The activin-A to follistatin ratio may influence the clinical presentation of PTB, such as preterm labor or PPROM.

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.3K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
9